Your session is about to expire
← Back to Search
VIPES for Balance Disorder
Study Summary
This trial is testing a new way to improve balance for people with balance disorders by stimulating the vestibular system.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are unable to complete the required tests because you have severe symptoms or can't stand without help.
- Group 1: Stochastic Vestibular Stimulation (SVS) Condition
- Group 2: Control Condition
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical trial accommodate individuals over the age of 25?
"This research is solely accepting patients aged between 21 and 55 years old."
What is the current enrollment size of this medical experiment?
"Affirmative, the information found on clinicaltrials.gov demonstrates that this experiment is presently seeking out participants. This study was first published on September 1st 2022 and has since been updated on September 6th 2022. The research team needs to recruit 30 people from one single location."
Are there any open recruitment slots for this scientific experiment?
"According to records on clinicaltrials.gov, this medical experiment is actively recruiting patients and was initially published September 1st 2022 with the last edit done on September 6th 2022."
Do I qualify for inclusion in this experiment?
"Candidates aged between 21 and 55, who have been diagnosed with a balance disorder, can apply to this clinical trial. Approximately 30 patients will be accepted into the study."
Share this study with friends
Copy Link
Messenger